pharma · Melanoma · HIV Infections
Bristol Myers Squibb
Bristol-Myers Squibb
Bristol Myers Squibb clinical programs — 12 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 3401 Princeton Pike, Lawrence Township, NJ 08648, US
- Employees
- 38,146
- Programs
- 40
- Drugs
- 17
- Patents
- 25
Bristol Myers Squibb projects
12 ClinicalTrials.gov programs sponsored by Bristol Myers Squibb.
Bristol Myers Squibb has 12 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
BMS-986165
Bristol-Myers Squibb
Systemic Lupus Erythematosus
1 trial -
BMS-986165
Bristol-Myers Squibb
Granulomatous Colitis
1 trial -
BMS-986165
Bristol-Myers Squibb
Lupus Nephritis
1 trial -
BMS-986466
Bristol-Myers Squibb
Advanced Solid Tumors
1 trial -
BMS-986504
Bristol-Myers Squibb
Solid Tumors
1 trial -
Dasatinib
Bristol-Myers Squibb
Chronic Myeloid Leukemia
1 trial -
Deucravacitinib
Bristol-Myers Squibb
Alopecia Areata
1 trial -
Nivolumab
Bristol-Myers Squibb
Hepatocellular Carcinoma
1 trial -
Nivolumab
Bristol-Myers Squibb
Prostate Cancer
1 trial -
Relatlimab
Bristol-Myers Squibb
Neoplasms by Site
1 trial -
nivolumab
Bristol-Myers Squibb
Neoplasms by Site
1 trial -
vinflunine
Bristol-Myers Squibb
Transitional Cell Carcinoma
1 trial
Frequently asked questions
How many clinical projects does Bristol Myers Squibb have?
12 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.